Clinical Trial Update: Neoadjuvant Chemotherapy Combined With Cetuximab for EGFR Wild Type Locally Advanced Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating neoadjuvant chemotherapy combined with cetuximab in EGFR wild-type locally advanced rectal cancer (Stage III).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Cetuximab (cetuximab)

Snippet

Sponsor: RenJi Hospital | Conditions: Rectal Cancer Stage III | Phase 2 | Status: ACTIVE_NOT_RECRUITING